Table of Contents
Journal of Amino Acids
Volume 2013 (2013), Article ID 251398, 13 pages
http://dx.doi.org/10.1155/2013/251398
Research Article

The Antitumor Peptide CIGB-552 Increases COMMD1 and Inhibits Growth of Human Lung Cancer Cells

1Department of Genomic, Center for Genetic Engineering and Biotechnology, Cubanacan, P.O. Box 6162, 10600 Havana, Cuba
2Pharmaceutical Department, Laboratory of Cancer Biology, Center for Genetic Engineering and Biotechnology, Cubanacan, P.O. Box 6162, 10600 Havana, Cuba
3Cell Biology Unit, Institute Pasteur of Montevideo, Mataojo 2020, 11400 Montevideo, Uruguay
4Synthetic Peptide Group, Physical Chemistry Department, Center for Genetic Engineering and Biotechnology, Cubanacan, P.O. Box 6162, 10600 Havana, Cuba
5Center of Studies for Research and Biological Evaluations, Pharmacy and Food Sciences College, University of Havana, 19250 Havana, Cuba

Received 18 October 2012; Revised 12 December 2012; Accepted 12 December 2012

Academic Editor: Michele Caraglia

Copyright © 2013 Julio R. Fernández Massó et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. G. Vallespi, J. R. Fernandez, I. Torrens et al., “Identification of a novel antitumor peptide based on the screening of an Ala-library derived from the LALF32-51 region,” Journal of Peptide Science, vol. 16, no. 1, pp. 40–47, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Guerra Vallespi, J. R. Fernandez Masso, A. Musacchio Lasa, J. Gil Valdez, O. Reyes Acosta, and B. Oliva Arguellez, “Cancer Therapy method,” WO/2011/150897, 2011.
  3. P. de Bie, B. van de Sluis, L. Klomp, and C. Wijmenga, “The many faces of the copper metabolism protein MURR1/COMMD1,” Journal of Heredity, vol. 96, no. 7, pp. 803–811, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Chang, Y. Ke, K. Ly, and F. J. McDonald, “COMMD1 regulates the delta epithelial sodium channel (δENaC) through trafficking and ubiquitination,” Biochemical and Biophysical Research Communications, vol. 411, no. 3, pp. 506–511, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. P. de Bie, B. van de Sluis, E. Burstein et al., “Characterization of COMMD protein-protein interactions in NF-κB signalling,” Biochemical Journal, vol. 398, no. 1, pp. 63–71, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. B. van de Sluis, P. Muller, K. Duran et al., “Increased activity of hypoxia-inducible factor 1 is associated with early embryonic lethality in Commd1 null mice,” Molecular and Cellular Biology, vol. 27, no. 11, pp. 4142–4156, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Geng, T. Wittwer, O. Dittrich-Breiholz, M. Kracht, and M. L. Schmitz, “Phosphorylation of NF-κB p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific proteasomal elimination,” EMBO Reports, vol. 10, no. 4, pp. 381–386, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. G. N. Maine, X. Mao, C. M. Komarck, and E. Burstein, “COMMD1 promotes the ubiquitination of NF-κB subunits through a cullin-containing ubiquitin ligase,” The EMBO Journal, vol. 26, no. 2, pp. 436–447, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Materia, M. A. Cater, L. W. Klomp, J. F. Mercer, and S. la Fontaine, “Clusterin and COMMD1 independently regulate degradation of the mammalian copper ATPases ATP7A and ATP7B,” The Journal of Biological Chemistry, vol. 287, no. 4, pp. 2485–2499, 2012. View at Publisher · View at Google Scholar
  10. B. van de Sluis, A. J. Groot, J. Vermeulen et al., “COMMD1 promotes pVHL and O2-independent proteolysis of HIF-1α via HSP90/70,” PLoS One, vol. 4, no. 10, Article ID e7332, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Xiao and J. Fu, “NF-κB and cancer: a paradigm of Yin-Yang,” American Journal of Cancer Research, vol. 1, no. 2, pp. 192–221, 2011. View at Google Scholar
  12. E. Poon, A. L. Harris, and M. Ashcroft, “Targeting the hypoxia-inducible factor (HIF) pathway in cancer,” Expert Reviews in Molecular Medicine, vol. 11, p. e26, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. B. van de Sluis, X. Mao, Y. Zhai et al., “COMMD1 disrupts HIF-1α/β dimerization and inhibits human tumor cell invasion,” Journal of Clinical Investigation, vol. 120, no. 6, pp. 2119–2130, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Camacho, G. Coulouris, V. Avagyan et al., “BLAST+: Architecture and applications,” BMC Bioinformatics, vol. 10, article 421, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Vancurova, V. Miskolci, and D. Davidson, “NF-κB activation in tumor necrosis factor α-stimulated neutrophils is mediated by protein kinase Cδ. Correlation to nuclear IκBα,” Journal of Biological Chemistry, vol. 276, no. 23, pp. 19746–19752, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Towbin and J. Gordon, “Immunoblotting and dot immunobinding. Current status and outlook,” Journal of Immunological Methods, vol. 72, no. 2, pp. 313–340, 1984. View at Google Scholar · View at Scopus
  17. C. A. Schneider, W. S. Rasband, and K. W. Eliceiri, “NIH Image to ImageJ: 25 years of image analysis,” Nature Methods, vol. 9, no. 7, pp. 671–675, 2012. View at Publisher · View at Google Scholar
  18. W. Cui, D. D. Taub, and K. Gardner, “qPrimerDepot: a primer database for quantitative real time PCR,” Nucleic Acids Research, vol. 35, no. 1, pp. D805–D809, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. S. A. Bustin, J. F. Beaulieu, J. Huggett et al., “MIQE précis: practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments,” BMC Molecular Biology, vol. 11, article 74, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Vandesompele, K. de Preter, F. Pattyn et al., “Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes,” Genome biology, vol. 3, no. 7, p. RESEARCH0034, 2002. View at Google Scholar · View at Scopus
  21. M. W. Pfaffl, G. W. Horgan, and L. Dempfle, “Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR,” Nucleic Acids Research, vol. 30, no. 9, p. e36, 2002. View at Google Scholar · View at Scopus
  22. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Google Scholar · View at Scopus
  23. H. Ukeda, S. Maeda, T. Ishii, and M. Sawamura, “Spectrophotometric assay for superoxide dismutase based on tetrazolium salt 3′-{1-[(phenylamino)-carbonyl]-3,4-tetrazolium}-bis(4-methoxy-6-nitro)benzenesulfonic acid hydrate reduction by xanthine-xanthine oxidase,” Analytical Biochemistry, vol. 251, no. 2, pp. 206–209, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Witko-Sarsat, M. Friedlander, T. N. Khoa et al., “Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure,” Journal of Immunology, vol. 161, no. 5, pp. 2524–2532, 1998. View at Google Scholar · View at Scopus
  25. I. Erdelmeier, D. Gérard-Monnier, J. C. Yadan, and J. Chaudière, “Reactions of N-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Mechanistic aspects of the colorimetric assay of lipid peroxidation,” Chemical Research in Toxicology, vol. 11, no. 10, pp. 1184–1194, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. I. F. F. Benzie and J. J. Strain, “The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay,” Analytical Biochemistry, vol. 239, no. 1, pp. 70–76, 1996. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Zoubeidi, S. Ettinger, E. Beraldi et al., “Clusterin facilitates COMMD1 and I-κB degradation to enhance NF-κB activity in prostate cancer cells,” Molecular Cancer Research, vol. 8, no. 1, pp. 119–130, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. P. A. J. Muller, B. V. de Sluis, A. J. Groot et al., “Nuclear-cytosolic transport of COMMD1 regulates NF-κB and HIF-1 activity,” Traffic, vol. 10, no. 5, pp. 514–527, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. H. C. Thoms, C. J. Loveridge, J. Simpson et al., “Nucleolar targeting of RelA(p65) is regulated by COMMD1-dependent ubiquitination,” Cancer Research, vol. 70, no. 1, pp. 139–149, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. W. I. M. Vonk, C. Wijmenga, R. Berger, B. van de Sluis, and L. W. J. Klomp, “Cu,Zn superoxide dismutase maturation and activity are regulated by COMMD1,” Journal of Biological Chemistry, vol. 285, no. 37, pp. 28991–29000, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Halliwell, “Oxidative stress and cancer: have we moved forward?” Biochemical Journal, vol. 401, no. 1, pp. 1–11, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Vlieghe, V. Lisowski, J. Martinez, and M. Khrestchatisky, “Synthetic therapeutic peptides: science and market,” Drug Discovery Today, vol. 15, no. 1-2, pp. 40–56, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. G. N. Maine, X. Mao, P. A. Muller, C. M. Komarck, L. W. J. Klomp, and E. Burstein, “COMMD1 expression is controlled by critical residues that determine XIAP binding,” Biochemical Journal, vol. 417, no. 2, pp. 601–609, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Ben-Neriah and M. Karin, “Inflammation meets cancer, with NF-κB as the matchmaker,” Nature Immunology, vol. 12, no. 8, pp. 715–723, 2011. View at Google Scholar
  35. G. N. Maine and E. Burstein, “COMMD proteins and the control of the NFκB pathway,” Cell Cycle, vol. 6, no. 6, pp. 672–676, 2007. View at Google Scholar · View at Scopus
  36. H. Pelicano, D. Carney, and P. Huang, “ROS stress in cancer cells and therapeutic implications,” Drug Resistance Updates, vol. 7, no. 2, pp. 97–110, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. A. A. Dayem, H. Y. Choi, J. H. Kim, and S. G. Cho, “Role of oxidative stress in stem, cancer, and cancer stem cells,” Cancers, vol. 2, no. 2, pp. 859–884, 2010. View at Publisher · View at Google Scholar · View at Scopus